• 
• 
• 
• 

FDA News and Drug Updates

FDA News

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL

Welcome to the Fourth Annual Oncology Guide to New FDA Approvals

Side-Effects Management

NCCN Issues First Guideline for Immunotherapy-Related Adverse Events

Wayne Kuznar

Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy-Induced Neutropenia

Audrey Andrews

Understanding Immunotherapy Late Adverse Effects in Cancer Survivors

Meg Barbor, MPH

Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer

Discontinuing Immunotherapy Because of Adverse Effects May Not Compromise Efficacy

Phoebe Starr

View All Side-Effects Management Articles

Immunotherapy

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

CAR T-Cell Therapy Fills Unmet Needs in Leukemia and Lymphoma

Wayne Kuznar

Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy

Wayne Kuznar

CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring

Wayne Kuznar

Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer

Phoebe Starr

View All Immunotherapy Articles

Conference Correspondent

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain

Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation

Graft-versus-Host Disease: Breakthroughs on the Horizon

Basket Clinical Trials: A New Era in Cancer Treatment

Burnout Rates High for Pharmacists in Hematopoietic Stem-Cell Transplantation

Chemotherapy Treatment Considerations in Special Patient Populations

Nivolumab/Ipilimumab Combination Extends Survival for Patients with Melanoma

View All Conference Correspondent Articles

Most Popular Articles

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

TOP - August 2019, Vol 12, No 3 - Immunotherapy

FDA News

TOP - August 2019, Vol 12, No 3 - FDA Approvals

FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs

Phoebe Starr

TOP - August 2019, Vol 12, No 3 - ASCO

The Evolving Role of Precision Medicine in Clinical Practice

Meg Barbor, MPH

TOP - August 2019, Vol 12, No 3 - HOPA

Enzalutamide or Apalutamide Added to ADT Are 2 New Options for Hormone-Sensitive Prostate Cancer

Phoebe Starr

TOP - August 2019, Vol 12, No 3 - Prostate Cancer